Evidence map›Paper›PMID 41983571›Full record

ReviewFEMS microbiology reviews2026

Translation quality control in Pseudomonas aeruginosa: current knowledge and perspectives.

Bastien L'Hermitte, Reynald Gillet, Christine Baysse

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bastien L'HermitteUniversity of Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, 35000 Rennes, France.ORCID 0009-0009-1822-1796
Reynald GilletUniversity of Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, 35000 Rennes, France.ORCID 0000-0001-9458-9503
Christine BaysseUniversity of Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, 35000 Rennes, France.ORCID 0000-0003-1318-2192

Funding

Agence Nationale de la Recherche ANR-23-CE18-0031-01Association Vaincre la Mucoviscidose RF20220503018Association Vaincre la Mucoviscidose RF20240503521Fondation pour la Recherche Médicale EQU202203014663
6 · The paper itself

Abstract

The fitness and virulence of Pseudomonas aeruginosa rely on its ability to maintain a functional pool of ribosomes, which are essential for protein synthesis. This review explores the intricate ways of ribosome protection, rescue, and hibernation, by which P. aeruginosa preserves ribosome functionality under stress. These processes enhance the adaptability and resistance of this pathogen to ribosome-targeting antibiotics and present significant challenges to current therapeutic strategies. By highlighting recent discoveries and identifying promising directions for future research, this review aims to explore potential targets for innovative drug discovery.

Indexed as

Protein BiosynthesisPseudomonas aeruginosaRibosomesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialAnti-Bacterial AgentsBacterial Proteinsantibiotic resistancePseudomonas aeruginosaribosome hibernationribosome protectionribosome quality controlribosome rescue

Identifiers

PMID41983571
PMCPMC13159725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.